India's Torrent Pharma rises to record high after Q1 results
BUZZ-India's Torrent Pharma rises to record high after Q1 results ** Shares of Torrent Pharmaceuticals TORP.NS rise as much as 5.5% to their record high of 5,140.70 rupees
** Drugmaker TQ1 consol rev up 5.5% y/y while profit rises 3.3% helped by domestic sales
** Co's US revenues at 4.18 billion rupees for Q1,up 36% y/y
** Twenty nine analysts have a "buy" rating on avg; median PT is 5,000 rupees - data compiled by LSEG
** YTD, TORP up ~32%
(Reporting by Urvi Dugar in Bengaluru)
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says